Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer
Background: Patients with metastatic colorectal cancer (mCRC) carrying a deficit in the mismatch repair system/microsatellite instability (dMMR/MSI) show great responses to immune checkpoint inhibitors. However, 30% of patients with dMMR/MSI are primarily immunoresistant, and another 30% develop sec...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2024-09-01
|
| Collection: | ESMO Gastrointestinal Oncology |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S294981982400030X |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
